The Society of British Neurological Surgeons

Neurosurgical National Audit Programme

About Us Cookies Login

Surgeon

Mr Stuart Smith BM BCh PhD FRCS
Professional Title Consultant Neurosurgeon
GMC Number 4740278
Personal Email stuart.smith@nuh.nhs.uk
Secretary Mary Miller 01159249924 ext 61102 mary.miller@nuh.nhs.uk
SBNS Member? Yes

Hospitals

Training


BA Oxford University 1997 BM BCh Oxford University 2000 FRCS England 2009 PhD University of Nottingham 2012

2013

Oxford University 1994-2000

East Midlands Neurosurgery Training Programme 2004-2013 NIHR Neuro-Oncology Research Fellow 2009-2012

Professional Activity


Clinical Associate Professor Neurosugery University of Nottingham Brain and CNS NIHR Cancer Research Lead, East Midlands

Society of British Neurological Surgeons; British Neuro-Oncology Society

Clinical Activity


Neuro-oncology including 5ALA fluorescence guided surgery, awake craniotomy, ultrasound guided surgery, low grade glioma surgery

Core member Neuro-Oncology MDT; Research Lead for Neurosurgery Dept.

Research


I am developing an active translational and clinical research programme in Nottingham, collaborating with the Children's Brain Tumour Research Centre, extending their work to an all age programme. I am particularly interested in high grade glial tumours, with studies running looking at drug delivery to these tumours, intra-tumour heterogeneity, microRNA profiling and metabolic control within these tumours.

1. Smith SJ, Rahman CV, Clarke PA, Ritchie AA, Gould TW, Ward JH, Shakesheff KM, Grundy RG and Rahman R Surgical delivery of drug-releasing poly(lactic-co-glycolic acid) / poly(ethylene glycol) paste with in-vivo effects against glioblastoma Annals RCSEng 2. Rahman CV, Smith SJ, Morgan PS, Langmack KA, Macarthur DC, Rose FRAJ, Shakesheff KM, Grundy RG, Rahman R Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable micro-particle based matrix. PloS one. 2013;8(10):e77435. PubMed PMID: 24155955. Pubmed Central PMCID: PMC3796488. Epub 2013/10/25. eng. 3. Smith SJ, Wilson M, Ward JH, Rahman CV, Peet AC, Macarthur DC, Rose FRAJ, Grundy RG, Rahman R Recapitulation of neoplastic phenotypes and molecular signatures in 3D brain cancer aggregates with decreased sensitivity to histone deacetylase inhibition. PLOSone 2012;7(12):e52335. 4. Smith SJ*, Tilly H, Macarthur DC, Lowe J, Coyle B, Grundy RG CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma. Acta Neuropathologica 2012 124(1):99-110 PMID: 22311740 IF: 9.7 5. Smith SJ, Long A, Barrow JH, Macarthur DC, Coyle B, Grundy RG Pediatric High Grade Glioma : Identification of Poly(ADP-ribose) Polymerase as a Potential Therapeutic Target Neuro-Oncology 2011 13(11):1171-77 IF: 6.1

Outcome Report

SBNS
Understanding activity pie charts


What does the Consultant activity pie chart show?

The Consultant activity pie charts represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.

Please note that for Consultants who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.

Elective Procedural Case-mix and Case Volume
Image

SBNS
Understanding mortality funnel plot charts

What does the Consultant funnel plot chart show?

The Hospital Consultant mortality funnel plot represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.

The mortality presented here is for three years: April 2014 – March 2017. Please note that for Consultant who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.

The horizontal yellow line represents the national average mortality. The solid black lines above and below the yellow line are the control limits. The upper control limit represents the highest expected mortality rate. The Consultant's outcome is highlighted in magenta.

30 Day Risk Adjusted Elective Procedural Mortality
Image

The outcomes of this consultant are within the expected range

Understanding the risk-adjusted mortality rate

Risk adjustment (or case-mix adjustment) takes into account patient risk factors to calculate a predicted mortality rate. This means that hospitals or consultants who see higher risk patients have their mortality rate adjusted to account for the factors that put these patients at greater risk.

Understanding the 'funnel plot' diagram

The funnel plot displays the risk-adjusted elective procedural mortality ratio for each consultant plotted against the expected number of mortalities for that consultant. The expected number of mortalities for each consultant will vary depending on the number of procedures they have performed and the risk profile of the patients they have treated. The horizontal yellow line represents the expected ratio. The solid black line above the chart is known as a ‘control limit’. This control limit represents the highest expected mortality rate. Risk-adjusted rates appearing beneath this line are within the normal range.

Back to Surgeons List